Scientist, Bioinformatics (Oncology / Immune-Oncology)
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Tarrytown, NY, United States
- Start date
- Sep 4, 2020
View more
- Discipline
- Science/R&D, Bioinformatics, Biotechnology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
As a Bioinformatics Scientist, a typical day may include:
- Lead bioinformatic studies in oncolytic virus treatments for cancer field.
- Work in concert with IO clinical and pre-clinical teams to design molecular profiling experiments, draft data analysis plans, and provide critical analytics support.
- Prepare clear, concise and easy-to-understand presentations and documentations for collaborators, senior management and government agencies.
- Publish and present novel findings in peer-reviewed journals and conferences.
- Design, develop, and implement tools for processing and analyzing high-throughput next-generation sequencing data, including but not limited to single cell sequencing, WGS, ExomeSeq, RNASeq, copy number, methylation data, etc.
- Contribute to team efforts of developing Molecular Profiling strategies and benchmark the standard methodology.
To be considered for this opportunity, you must have a PhD degree in bioinformatics, computer science, or a related field and 1 + years relevent experience; Working experience in cancer genomics, including but not limited to NGS reads mapping, WGS, transposons, transcriptional elements, mutations/neo-antigens, alternative splicing, fusion proteins, translocation, etc.; Experience and knowledge about viral genomes and integration of viral and cancer genomes are desired; Solid programming skills and proficie
MPDS
#LI-GP1
-
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert